Hematological effects of zidovudine prophylaxis in newborn infants with and without prenatal exposure to zidovudine

Journal of Medical Virology

Volumn 83, Issue 3, 2011, Pages 551-556

  Baroncelli, Silvia ^a   Pinnetti, Carmela ^b   Genovese, Orazio ^b   Tamburrini, Enrica ^b   Floridia, Marco ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

Antiretroviral therapy; HIV; Pediatrics anemia; Zidovudine

Indexed keywords

ATAZANAVIR PLUS RITONAVIR; DARUNAVIR PLUS RITONAVIR; HEMOGLOBIN; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; NELFINAVIR; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR PLUS SAQUINAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; ZIDOVUDINE;

ADULT; ADVERSE OUTCOME; ANTIVIRAL THERAPY; APGAR SCORE; ARTICLE; BIRTH WEIGHT; BLOOD EXAMINATION; BLOOD TOXICITY; CLINICAL EVALUATION; CONTROLLED STUDY; DRUG EFFECT; ERYTHROCYTE COUNT; ETHNICITY; FEMALE; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; NEWBORN; NEWBORN ANEMIA; OUTCOME ASSESSMENT; PERINATAL PERIOD; PREGNANT WOMAN; PRENATAL DRUG EXPOSURE; PROPHYLAXIS; RISK ASSESSMENT; RISK REDUCTION; SIDE EFFECT; TREATMENT DURATION; VIROLOGY;

ANTI-HIV AGENTS; ANTIBIOTIC PROPHYLAXIS; FEMALE; HEMATOLOGIC TESTS; HIV INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PRENATAL EXPOSURE DELAYED EFFECTS; TREATMENT OUTCOME; ZIDOVUDINE;

EID: 78851472222     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21986     Document Type: Article

References (19)

1. Bae WH, Wester C, Smeaton LM, Shapiro RL, Lockman S, Onyait K, Thior I, Essex M. 2008. Hematologic and hepatic toxicities associated with antenatal and postnatal exposure to maternal highly active antiretroviral therapy among infants. AIDS 22: 1633-1640.
2. Baroncelli S, Tamburrini E, Ravizza M, Dalzero S, Tibaldi C, Ferrazzi E, Anzidei G, Fiscon M, Alberico S, Martinelli P, Placido G, Guaraldi G, Pinnetti C, Floridia M, Italian Group on Surveillance on Antiretroviral Treatment in Pregnancy. 2009. Antiretroviral treatment in pregnancy: A six-year perspective on recent trends in prescription patterns, viral load suppression, and pregnancy outcomes. AIDS Patient Care STDs 23: 513-520.
3. Briand N, Lallemant M, Jourdain G, Techapalokul S, Tunthanathip P, Suphanich S, Chanpoo T, Traisathit P, McIntosh K, Le Coeur S. 2007. Haematological safety of perinatal zidovudine in pregnant HIV-1-infected women in Thailand: Secondary analysis of a randomized trial. PLoS Clin Trials 2: e11.
4. Bunders MJ, Bekker V, Scherpbier HJ, Boer K, Godfried M, Kuijpers TW. 2005. Haematological parameters of HIV-1-uninfected infants born to HIV-1-infected mothers. Acta Paediatr 94: 1571-1577.
5. Christensen RD, Henry E, Jopling J, Wiedmeier SE. 2009. The CBC: Reference ranges for neonates. Semin Perinatol 33: 3-11.
6. El Beitune P, Duarte G. 2006. Antiretroviral agents during pregnancy: Consequences on hematologic parameters in HIV-exposed, uninfected newborn infant. Eur J Obstet Gynecol Reprod Biol 128: 59-63.
7. Eyer-Silva WA, Arabe J, Pinto JF, Morais-De-Sá CA. 2001. Macrocytosis in patients on stavudine. Scand J Infect Dis 33: 239-240.
8. Feiterna-Sperling C, Weizsaecker K, Bührer C, Casteleyn S, Loui A, Schmitz T, Wahn V, Obladen M. 2007. Hematologic effects of maternal antiretroviral therapy and transmission prophylaxis in HIV-1-exposed uninfected newborn infants. J Acquir Immune Defic Syndr 45: 43-51.
9. Floridia M, Ravizza M, Tamburrini E, Anzidei G, Tibaldi C, Maccabruni A, Guaraldi G, Alberico S, Vimercati A, Degli Antoni A, Ferrazzi E, Italian Group on Surveillance on Antiretroviral Treatment in Pregnancy. 2006. Diagnosis of HIV infection in pregnancy: Data from a national cohort of pregnant women with HIV in Italy. Epidemiol Infect 134: 1120-1127.
10. Le Chenadec J, Mayaux MJ, Guihenneuc-Jouyaux C, Blanche S, Enquête Périnatale Française Study Group. 2003. Perinatal antiretroviral treatment and hematopoiesis in HIV-uninfected infants. AIDS 17: 2053-2061.
11. Mandelbrot L, Landreau-Mascaro A, Rekacewicz C, Berrebi A, Bénifla JL, Burgard M, Lachassine E, Barret B, Chaix ML, Bongain A, Ciraru-Vigneron N, Crenn-Hébert C, Delfraissy JF, Rouzioux C, Mayaux MJ, Blanche S, Agence Nationale de Recherches sur le SIDA (ANRS) 075 Study Group. 2001. Lamivudine-zidovudine combination for prevention of maternal-infant transmission of HIV-1. JAMA 285: 2083-2093.
12. Marzolini C, Rudin C, Decosterd LA, Telenti A, Schreyer A, Biollaz J, Buclin T, Swiss Mother+Child HIV Cohort Study. 2002. Transplacental passage of protease inhibitors at delivery. AIDS 16: 889-893.
13. Moyle G. 2002. Anaemia in persons with HIV infection: Prognostic marker and contributor to morbidity. AIDS Rev 4: 13-20.
14. National Institute of Allergy and Infectious Diseases, Division of AIDS. 2004. Division of AIDS Table for Grading the Severity of Adult and Pediatric Adverse Events. Bethesda, MD: US Department of Health and Human Services. December 2004. Clarification August 2009. Available at:.
15. Pacheco SE, McIntosh K, Lu M, Mofenson LM, Diaz C, Foca M, Frederick M, Handelsman E, Hayani K, Shearer WT, Women and Infants Transmission Study. 2006. Effect of perinatal antiretroviral drug exposure on hematologic values in HIV-uninfected children: An analysis of the women and infants transmission study. J Infect Dis 194: 1089-1097.
16. Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. 2010. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. May 24, 2010; pp 1-117. Available at May 24, 2010; pp 1-117.
17. Romanelli F, Empey K, Pomeroy C. 2002. Macrocytosis as an indicator of medication (zidovudine) adherence in patients with HIV infection. AIDS Patient Care STDS 16: 405-411.
18. Sullivan PS, Hanson DL, Chu SY, Jones JL, Ward JW. 1998. Epidemiology of anemia in human immunodeficiency virus (HIV)-infected persons: Results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood 91: 301-308.
19. World Health Organization, United Nations University, UNICEF Iron Deficiency Anaemia. 2001. Assessment, prevention and control. Available at:.